
Health
Makers of GLP-1 drugs ordered to add warnings about rare eye condition
The FDA mandates that makers of popular weight-loss drugs include warning labels about a rare eye condition linked to sudden vision loss.

The FDA mandates that makers of popular weight-loss drugs include warning labels about a rare eye condition linked to sudden vision loss.
